{
  "abstract": "Respiratory syncytial virus (RSV) is a leading cause of hospitalisation for lower respiratory tract infection in children. Despite not being included in Norway’s national immunisation programme and requiring out-of-pocket payment, maternal RSV vaccination coverage reached 51% by September 2026. Coverage varied markedly by maternal country of birth, with lower uptake among women born outside Norway. Within Oslo, uptake appeared to reflect district-level socioeconomic factors. These inequalities suggest that lack of government funding is an important driver of unequal protection.",
  "abstract_shown": true,
  "affiliations": [
    "Norwegian Institute of Public Health, Oslo, Norway"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Fredrik Skår"
    },
    {
      "affs": [
        0
      ],
      "name": "Hinta Meijerink"
    },
    {
      "affs": [
        0
      ],
      "name": "Margrethe Greve-Isdahl"
    },
    {
      "affs": [
        0
      ],
      "name": "Anja Bråthen Kristoffersen"
    },
    {
      "affs": [
        0
      ],
      "name": "Jacob Dag Berild"
    },
    {
      "affs": [
        0
      ],
      "name": "Suzanne Campbell"
    },
    {
      "affs": [
        0
      ],
      "name": "Håkon Bøås"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/07ybk4ev6347k.bib",
  "cited_by": 0,
  "doi": "10.2807/1560-7917.es.2026.31.44.2600882",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13743905/",
  "id": "07ybk4ev6347k",
  "issns": [
    "1025-496X",
    "1560-7917"
  ],
  "landing_url": "https://doi.org/10.2807/1560-7917.es.2026.31.44.2600882",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Rapid Communication"
    ],
    [
      "openalex",
      "2713|Respiratory viral infections research"
    ]
  ],
  "openalex": "W7225399932",
  "pdf_url": "https://www.eurosurveillance.org/deliver/fulltext/eurosurveillance/31/44/eurosurv-31-44-1.pdf?itemId=%2Fcontent%2F10.2807%2F1560-7917.ES.2026.31.44.2600882&mimeType=pdf&containerItemId=content/eurosurveillance",
  "pmcid": "PMC13743905",
  "pmid": "42990029",
  "published": "2026-11-05",
  "publisher": "European Centre for Disease Prevention and Control",
  "ris": "https://research.draconitic.com/paper/07ybk4ev6347k.ris",
  "sources": [
    {
      "first_seen": "2026-11-11T12:21:31Z",
      "native_id": "PMC13743905",
      "source": "pmc",
      "url": "https://doi.org/10.2807/1560-7917.es.2026.31.44.2600882"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Respiratory viral infections research",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Maternal RSV vaccination in the absence of a nationally funded programme: inequalities in coverage in Norway, 2024 to 2026",
  "title_text": "Maternal RSV vaccination in the absence of a nationally funded programme: inequalities in coverage in Norway, 2024 to 2026",
  "type": "peer-reviewed",
  "updated_at": "2026-11-11T12:21:31Z",
  "url": "https://research.draconitic.com/paper/07ybk4ev6347k",
  "venue": "Eurosurveillance",
  "versions": []
}